ASH Clinical News ACN_3.13_FULL_ISSUE_DIGITAL | Page 62

Literature Scan Multivariate Analysis of OS Associated With Exclusion Criteria TABLE 3. Exclusion Criteria HR 95% CI p Value ECOG PS (3 or 4 vs. <3) 1.86 1.19-2.92 0.007 Platelet count ≤1.5x10 /L 2.08 1.53-2.82 <0.001 Creatinine level >2.5 mg/dL 1.49 1.20-1.85 <0.001 AHCT 0.38 0.31-0.45 <0.001 9 OS = overall survival; HR = hazard ratio; ECOG PS = Eastern Cooperative Oncology Group performance status; AHCT = autologous hematopoietic cell transplantation Except for previous invasive malignancy and ISS stage, the factors also were statistically significant in a multivariate analysis, with a 2.08-fold increase in the risk of death related to low platelet count (p<0.001), a 1.49-fold increase for patients with elevated creatinine levels (p<0.001), and a 1.86-fold increase for ECOG performance status score of 3 or 4 (p=0.007; see TABLE 3 ). “The multivariate analysis of OS and eligibility criteria reinforces the premise that RCT eligibility criteria deselect patients with more advanced disease,” the authors wrote. Serious adverse events (AEs) were reported in a similar proportion of RCT- ineligible (66.8%) and -eligible (62.5%) pa- tients. Infections occurred in 29.3 percent and 23.1 percent of patients, respectively, and pneumonia occurred in 13.1 percent and 12.5 percent, respectively. Serious AEs